Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Airway hyperresponsiveness.

Paul M O'Byrne1, Mark D Inman

  • 1Firestone Institute for Respiratory Health, St. Joseph's Hospital, Hamilton, ON, Canada. oby-rnep@mcmaster.ca

Chest
|March 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

The journal of allergy and clinical immunology. Global·2026
Same author

Improved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroids.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Chest·2026
Same author

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

The European respiratory journal·2026
Same author

Inhaled anti-thymic stromal lymphopoietin antibody fragment, ecleralimab, in severe asthma: A placebo-controlled, multicenter, double-blind, randomized, phase 2b clinical trial.

American journal of respiratory and critical care medicine·2026
Same author

Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).

Respiratory research·2026
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

Airway hyperresponsiveness, a key asthma trait, involves heightened airway sensitivity. While allergens cause temporary increases, they don't fully explain the persistent hyperresponsiveness seen in asthma patients.

Area of Science:

  • Pulmonology
  • Allergy and Immunology

Background:

  • Airway hyperresponsiveness is a hallmark of asthma, characterized by increased airway sensitivity to constrictor agonists.
  • Measurements of airway responsiveness aid in diagnosing asthma, especially in patients with suggestive symptoms but no airflow obstruction.

Purpose of the Study:

  • To differentiate between transient allergen-induced airway hyperresponsiveness and persistent hyperresponsiveness in asthma.
  • To investigate the relationship between allergen exposure, airway inflammation, and asthma control.

Main Methods:

  • Assessment of airway responsiveness using inhaled constrictor agonists.
  • Evaluation of changes in airway hyperresponsiveness following allergen exposure.
  • Comparison of transient and persistent airway hyperresponsiveness mechanisms.

Related Experiment Videos

Main Results:

  • Inhaled allergens can transiently increase airway inflammation and hyperresponsiveness.
  • These allergen-induced changes are less pronounced than the persistent hyperresponsiveness observed in asthma.
  • Transient changes correlate with worsening asthma control, similar to persistent hyperresponsiveness.

Conclusions:

  • Transient allergen-induced airway hyperresponsiveness mechanisms do not fully account for persistent airway hyperresponsiveness in asthma.
  • Understanding these distinctions is crucial for accurate asthma diagnosis and management.